Listed

Abeona Therapeutics Inc.

ABEONasdaqCIK 318306HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$11.4m, Q2 FY2026
Operating income−$13.7m, Q2 FY2026
Net income−$20.2m, Q2 FY2026
Abeona Therapeutics Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-14, accession 0001493152-24-045340. Derived: 9-month figure less the 6-month figure.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0001493152-25-010978. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reported0.4Revenue, Q2 FY2025, three months to 2025-06-30$400.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021723. Derived: 9-month figure less the 6-month figure.Report this figure5.4Revenue, Q4 FY2025, three months to 2025-12-31$5.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure8.7Revenue, Q1 FY2026, three months to 2026-03-31$8.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure11.4Revenue, Q2 FY2026, three months to 2026-06-30$11.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported0.5Cost of revenue, Q3 FY2025, three months to 2025-09-30$488.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure1.0Cost of revenue, Q4 FY2025, three months to 2025-12-31$1.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure2.7Cost of revenue, Q1 FY2026, three months to 2026-03-31$2.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure4.2Cost of revenue, Q2 FY2026, three months to 2026-06-30$4.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure
Research and development$m7.1Research and development, Q3 FY2023, three months to 2023-09-30$7.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001493152-24-045340.Report this figure7.4Research and development, Q4 FY2023, three months to 2023-12-31$7.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-20, accession 0001493152-25-010978. Derived: 12-month figure less the 9-month figure.Report this figure7.2Research and development, Q1 FY2024, three months to 2024-03-31$7.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001641172-25-010516.Report this figure9.2Research and development, Q2 FY2024, three months to 2024-06-30$9.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001641172-25-023716.Report this figure8.9Research and development, Q3 FY2024, three months to 2024-09-30$8.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure9.0Research and development, Q4 FY2024, three months to 2024-12-31$9.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure9.9Research and development, Q1 FY2025, three months to 2025-03-31$9.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure5.9Research and development, Q2 FY2025, three months to 2025-06-30$5.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure4.2Research and development, Q3 FY2025, three months to 2025-09-30$4.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure6.7Research and development, Q4 FY2025, three months to 2025-12-31$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure9.6Research and development, Q1 FY2026, three months to 2026-03-31$9.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure5.0Research and development, Q2 FY2026, three months to 2026-06-30$5.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure
Selling, general and administrative$mnot reportednot reportednot reported8.6Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$8.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-14, accession 0001641172-25-023716.Report this figure6.4Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$6.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure7.7Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$7.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure9.8Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$9.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure17.1Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$17.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure19.3Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$19.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure18.8Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$18.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure19.5Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$19.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure15.8Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$15.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure
Operating income$m(11.3)Operating income, Q3 FY2023, three months to 2023-09-30−$11.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-045340.Report this figure(13.2)Operating income, Q4 FY2023, three months to 2023-12-31−$13.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-20, accession 0001493152-25-010978. Derived: 12-month figure less the 9-month figure.Report this figure(14.3)Operating income, Q1 FY2024, three months to 2024-03-31−$14.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001641172-25-010516.Report this figure(17.9)Operating income, Q2 FY2024, three months to 2024-06-30−$17.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001641172-25-023716.Report this figure(15.3)Operating income, Q3 FY2024, three months to 2024-09-30−$15.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure(16.7)Operating income, Q4 FY2024, three months to 2024-12-31−$16.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure(19.7)Operating income, Q1 FY2025, three months to 2025-03-31−$19.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure(22.8)Operating income, Q2 FY2025, three months to 2025-06-30−$22.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure(24.0)Operating income, Q3 FY2025, three months to 2025-09-30−$24.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure(22.9)Operating income, Q4 FY2025, three months to 2025-12-31−$22.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure(23.0)Operating income, Q1 FY2026, three months to 2026-03-31−$23.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure(13.7)Operating income, Q2 FY2026, three months to 2026-06-30−$13.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure
Interest expense$m0.1Interest expense, Q3 FY2023, three months to 2023-09-30$105.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-14, accession 0001493152-24-045340.Report this figure0.1Interest expense, Q4 FY2023, three months to 2023-12-31$109.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-20, accession 0001493152-25-010978. Derived: 12-month figure less the 9-month figure.Report this figure1.0Interest expense, Q1 FY2024, three months to 2024-03-31$952.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-15, accession 0001641172-25-010516.Report this figure1.1Interest expense, Q2 FY2024, three months to 2024-06-30$1.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-14, accession 0001641172-25-023716.Report this figure1.1Interest expense, Q3 FY2024, three months to 2024-09-30$1.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure1.1Interest expense, Q4 FY2024, three months to 2024-12-31$1.1m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure1.0Interest expense, Q1 FY2025, three months to 2025-03-31$998.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure1.0Interest expense, Q2 FY2025, three months to 2025-06-30$957.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure0.9Interest expense, Q3 FY2025, three months to 2025-09-30$901.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure0.9Interest expense, Q4 FY2025, three months to 2025-12-31$884.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure0.8Interest expense, Q1 FY2026, three months to 2026-03-31$830.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure0.7Interest expense, Q2 FY2026, three months to 2026-06-30$696.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reported15.5Income tax, Q2 FY2025, three months to 2025-06-30$15.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure(15.2)Income tax, Q3 FY2025, three months to 2025-09-30−$15.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure(0.2)Income tax, Q4 FY2025, three months to 2025-12-31−$215.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001493152-26-037576. Derived: 6-month figure less the 3-month figure.Report this figure
Net income$m(11.8)Net income, Q3 FY2023, three months to 2023-09-30−$11.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-045340.Report this figure(16.6)Net income, Q4 FY2023, three months to 2023-12-31−$16.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-20, accession 0001493152-25-010978. Derived: 12-month figure less the 9-month figure.Report this figure(31.6)Net income, Q1 FY2024, three months to 2024-03-31−$31.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001641172-25-010516.Report this figure7.4Net income, Q2 FY2024, three months to 2024-06-30$7.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001641172-25-023716.Report this figure(30.3)Net income, Q3 FY2024, three months to 2024-09-30−$30.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure(9.3)Net income, Q4 FY2024, three months to 2024-12-31−$9.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure(12.0)Net income, Q1 FY2025, three months to 2025-03-31−$12.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure109Net income, Q2 FY2025, three months to 2025-06-30$108.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure(5.2)Net income, Q3 FY2025, three months to 2025-09-30−$5.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure(20.5)Net income, Q4 FY2025, three months to 2025-12-31−$20.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure(17.1)Net income, Q1 FY2026, three months to 2026-03-31−$17.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure(20.2)Net income, Q2 FY2026, three months to 2026-06-30−$20.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure
Diluted EPS$ per share(0.48)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001493152-24-045340.Report this figurenot reported(1.16)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001641172-25-010516.Report this figure(0.26)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001641172-25-023716.Report this figure(0.63)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figurenot reported(0.24)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure1.71Diluted EPS, Q2 FY2025, three months to 2025-06-30$1.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure(0.10)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figurenot reported(0.30)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure(0.35)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure
Basic EPS$ per share(0.48)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001493152-24-045340.Report this figurenot reported(1.16)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001641172-25-010516.Report this figure0.19Basic EPS, Q2 FY2024, three months to 2024-06-30$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001641172-25-023716.Report this figure(0.63)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figurenot reported(0.24)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure2.07Basic EPS, Q2 FY2025, three months to 2025-06-30$2.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure(0.10)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figurenot reported(0.30)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure(0.35)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure

Balance sheet

Cash and equivalents$56.2m, Q2 FY2026
Long-term debt$1.7m, Q2 FY2026
Shareholders' equity$128.1m, Q2 FY2026
Abeona Therapeutics Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m4.7Cash and equivalents, Q3 FY2023, at 2023-09-30$4.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001493152-24-045340.Report this figure14.5Cash and equivalents, FY2023, at 2023-12-31$14.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-20, accession 0001493152-25-010978.Report this figure17.6Cash and equivalents, Q1 FY2024, at 2024-03-31$17.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001641172-25-010516.Report this figure34.4Cash and equivalents, Q2 FY2024, at 2024-06-30$34.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001641172-25-023716.Report this figure15.7Cash and equivalents, Q3 FY2024, at 2024-09-30$15.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure23.4Cash and equivalents, FY2024, at 2024-12-31$23.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-17, accession 0001493152-26-010413.Report this figure15.9Cash and equivalents, Q1 FY2025, at 2025-03-31$15.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure164Cash and equivalents, Q2 FY2025, at 2025-06-30$163.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure82.9Cash and equivalents, Q3 FY2025, at 2025-09-30$82.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure78.4Cash and equivalents, FY2025, at 2025-12-31$78.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure61.4Cash and equivalents, Q1 FY2026, at 2026-03-31$61.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure56.2Cash and equivalents, Q2 FY2026, at 2026-06-30$56.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure
Current assets$m57.3Current assets, Q3 FY2023, at 2023-09-30$57.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001493152-23-040323.Report this figure55.7Current assets, FY2023, at 2023-12-31$55.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-20, accession 0001493152-25-010978.Report this figure66.7Current assets, Q1 FY2024, at 2024-03-31$66.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001493152-24-019459.Report this figure126Current assets, Q2 FY2024, at 2024-06-30$125.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0001493152-24-031150.Report this figure113Current assets, Q3 FY2024, at 2024-09-30$112.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045340.Report this figure101Current assets, FY2024, at 2024-12-31$100.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-17, accession 0001493152-26-010413.Report this figure88.1Current assets, Q1 FY2025, at 2025-03-31$88.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-010516.Report this figure232Current assets, Q2 FY2025, at 2025-06-30$232.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001641172-25-023716.Report this figure216Current assets, Q3 FY2025, at 2025-09-30$216.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure205Current assets, FY2025, at 2025-12-31$204.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure183Current assets, Q1 FY2026, at 2026-03-31$183.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure165Current assets, Q2 FY2026, at 2026-06-30$164.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure
Total assets$m66.1Total assets, Q3 FY2023, at 2023-09-30$66.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001493152-23-040323.Report this figure64.0Total assets, FY2023, at 2023-12-31$64.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-20, accession 0001493152-25-010978.Report this figure74.8Total assets, Q1 FY2024, at 2024-03-31$74.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001493152-24-019459.Report this figure134Total assets, Q2 FY2024, at 2024-06-30$134.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0001493152-24-031150.Report this figure121Total assets, Q3 FY2024, at 2024-09-30$120.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001493152-24-045340.Report this figure109Total assets, FY2024, at 2024-12-31$108.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-17, accession 0001493152-26-010413.Report this figure99.4Total assets, Q1 FY2025, at 2025-03-31$99.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001641172-25-010516.Report this figure246Total assets, Q2 FY2025, at 2025-06-30$246.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001641172-25-023716.Report this figure231Total assets, Q3 FY2025, at 2025-09-30$231.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure220Total assets, FY2025, at 2025-12-31$219.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure198Total assets, Q1 FY2026, at 2026-03-31$198.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure180Total assets, Q2 FY2026, at 2026-06-30$179.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure
Current liabilities$m8.4Current liabilities, Q3 FY2023, at 2023-09-30$8.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001493152-23-040323.Report this figure13.4Current liabilities, FY2023, at 2023-12-31$13.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-20, accession 0001493152-25-010978.Report this figure11.9Current liabilities, Q1 FY2024, at 2024-03-31$11.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001493152-24-019459.Report this figure16.8Current liabilities, Q2 FY2024, at 2024-06-30$16.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0001493152-24-031150.Report this figure18.4Current liabilities, Q3 FY2024, at 2024-09-30$18.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045340.Report this figure16.6Current liabilities, FY2024, at 2024-12-31$16.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-17, accession 0001493152-26-010413.Report this figure18.0Current liabilities, Q1 FY2025, at 2025-03-31$18.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-010516.Report this figure34.5Current liabilities, Q2 FY2025, at 2025-06-30$34.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001641172-25-023716.Report this figure22.2Current liabilities, Q3 FY2025, at 2025-09-30$22.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure29.6Current liabilities, FY2025, at 2025-12-31$29.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure31.0Current liabilities, Q1 FY2026, at 2026-03-31$31.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure24.8Current liabilities, Q2 FY2026, at 2026-06-30$24.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure
Total liabilities$m44.0Total liabilities, Q3 FY2023, at 2023-09-30$44.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001493152-23-040323.Report this figure49.2Total liabilities, FY2023, at 2023-12-31$49.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-20, accession 0001493152-25-010978.Report this figure83.7Total liabilities, Q1 FY2024, at 2024-03-31$83.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001493152-24-019459.Report this figure60.8Total liabilities, Q2 FY2024, at 2024-06-30$60.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0001493152-24-031150.Report this figure74.8Total liabilities, Q3 FY2024, at 2024-09-30$74.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001493152-24-045340.Report this figure64.9Total liabilities, FY2024, at 2024-12-31$64.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-17, accession 0001493152-26-010413.Report this figure58.0Total liabilities, Q1 FY2025, at 2025-03-31$58.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001641172-25-010516.Report this figure82.7Total liabilities, Q2 FY2025, at 2025-06-30$82.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001641172-25-023716.Report this figure59.9Total liabilities, Q3 FY2025, at 2025-09-30$59.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure60.4Total liabilities, FY2025, at 2025-12-31$60.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure53.6Total liabilities, Q1 FY2026, at 2026-03-31$53.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure51.4Total liabilities, Q2 FY2026, at 2026-06-30$51.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure
Long-term debt$mnot reportednot reported18.1Long-term debt, Q1 FY2024, at 2024-03-31$18.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-15, accession 0001493152-24-019459.Report this figure16.1Long-term debt, Q2 FY2024, at 2024-06-30$16.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-12, accession 0001493152-24-031150.Report this figure14.2Long-term debt, Q3 FY2024, at 2024-09-30$14.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045340.Report this figure13.0Long-term debt, FY2024, at 2024-12-31$13.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-17, accession 0001493152-26-010413.Report this figure11.1Long-term debt, Q1 FY2025, at 2025-03-31$11.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-15, accession 0001641172-25-010516.Report this figure14.0Long-term debt, Q2 FY2025, at 2025-06-30$14.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-14, accession 0001641172-25-023716.Report this figure10.9Long-term debt, Q3 FY2025, at 2025-09-30$10.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure7.8Long-term debt, FY2025, at 2025-12-31$7.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure4.8Long-term debt, Q1 FY2026, at 2026-03-31$4.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure1.7Long-term debt, Q2 FY2026, at 2026-06-30$1.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure
Current portion of debt$mnot reportednot reportednot reported2.2Current portion of debt, Q2 FY2024, at 2024-06-30$2.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-12, accession 0001493152-24-031150.Report this figure4.4Current portion of debt, Q3 FY2024, at 2024-09-30$4.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045340.Report this figure5.9Current portion of debt, FY2024, at 2024-12-31$5.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-17, accession 0001493152-26-010413.Report this figure8.1Current portion of debt, Q1 FY2025, at 2025-03-31$8.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-010516.Report this figure5.6Current portion of debt, Q2 FY2025, at 2025-06-30$5.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-14, accession 0001641172-25-023716.Report this figure8.9Current portion of debt, Q3 FY2025, at 2025-09-30$8.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure12.2Current portion of debt, FY2025, at 2025-12-31$12.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure13.3Current portion of debt, Q1 FY2026, at 2026-03-31$13.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure13.3Current portion of debt, Q2 FY2026, at 2026-06-30$13.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure
Short-term borrowings$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m22.0Shareholders' equity, Q3 FY2023, at 2023-09-30$22.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001493152-24-045340.Report this figure14.8Shareholders' equity, FY2023, at 2023-12-31$14.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-17, accession 0001493152-26-010413.Report this figure(8.9)Shareholders' equity, Q1 FY2024, at 2024-03-31−$8.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0001641172-25-023716.Report this figure73.2Shareholders' equity, Q2 FY2024, at 2024-06-30$73.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure45.8Shareholders' equity, Q3 FY2024, at 2024-09-30$45.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure44.0Shareholders' equity, FY2024, at 2024-12-31$44.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure41.4Shareholders' equity, Q1 FY2025, at 2025-03-31$41.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure164Shareholders' equity, Q2 FY2025, at 2025-06-30$163.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure171Shareholders' equity, Q3 FY2025, at 2025-09-30$171.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure159Shareholders' equity, FY2025, at 2025-12-31$159.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure145Shareholders' equity, Q1 FY2026, at 2026-03-31$144.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure128Shareholders' equity, Q2 FY2026, at 2026-06-30$128.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure

Cash flow

Operating cash flow−$17.5m, Q2 FY2026
Capital expenditure$479.0k, Q2 FY2026
Abeona Therapeutics Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(5.7)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001493152-24-045340. Derived: 9-month figure less the 6-month figure.Report this figure(9.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$9.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-20, accession 0001493152-25-010978. Derived: 12-month figure less the 9-month figure.Report this figure(14.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$14.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001641172-25-010516.Report this figure(12.7)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$12.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001641172-25-023716. Derived: 6-month figure less the 3-month figure.Report this figure(12.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$12.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001493152-25-021723. Derived: 9-month figure less the 6-month figure.Report this figure(16.6)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$16.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure(18.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$18.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure(18.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$18.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001493152-26-037576. Derived: 6-month figure less the 3-month figure.Report this figure(21.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$21.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001493152-25-021723. Derived: 9-month figure less the 6-month figure.Report this figure(18.0)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$18.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure(19.8)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$19.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure(17.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$17.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001493152-26-037576. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$44.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001493152-24-045340. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$37.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-20, accession 0001493152-25-010978. Derived: 12-month figure less the 9-month figure.Report this figure0.7Capital expenditure, Q1 FY2024, three months to 2024-03-31$725.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0001641172-25-010516.Report this figure0.7Capital expenditure, Q2 FY2024, three months to 2024-06-30$711.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0001641172-25-023716. Derived: 6-month figure less the 3-month figure.Report this figure0.4Capital expenditure, Q3 FY2024, three months to 2024-09-30$404.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001493152-25-021723. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2024, three months to 2024-12-31$606.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure1.4Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure2.9Capital expenditure, Q2 FY2025, three months to 2025-06-30$2.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001493152-26-037576. Derived: 6-month figure less the 3-month figure.Report this figure2.5Capital expenditure, Q3 FY2025, three months to 2025-09-30$2.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001493152-25-021723. Derived: 9-month figure less the 6-month figure.Report this figure1.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-17, accession 0001493152-26-010413. Derived: 12-month figure less the 9-month figure.Report this figure0.9Capital expenditure, Q1 FY2026, three months to 2026-03-31$935.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure0.5Capital expenditure, Q2 FY2026, three months to 2026-06-30$479.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001493152-26-037576. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)57.05m, Q2 FY2026
Abeona Therapeutics Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares6.4Diluted shares (weighted), Q3 FY2022, three months to 2022-09-306,421,245 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001493152-23-040323.Report this figure16.9Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3116,904,024 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0001493152-24-019459.Report this figure18.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3018,017,874 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-12, accession 0001493152-24-031150.Report this figure24.8Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3024,797,564 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001493152-24-045340.Report this figure27.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3127,315,537 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001641172-25-010516.Report this figure51.2Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3051,226,715 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001641172-25-023716.Report this figure48.1Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3048,081,758 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure49.8Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3149,778,801 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure66.6Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3066,640,620 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure54.2Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3054,242,507 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001493152-25-021723.Report this figure56.6Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3156,620,920 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001493152-26-022614.Report this figure57.0Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3057,048,385 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure

Shares outstanding: 57.18mShares outstanding, period not labelled, at 2026-08-1057,184,017 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037576.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. Listed shows no prices and gives no investment advice.